Cardiac Event, Complication, Gender Discrimination
Conditions
Keywords
Cardiovascular involvement, COVID 19 disease, Gender difference
Brief summary
Aim of the study is to evaluate the prevalence and bring awareness ofcardiovascular complications in COVID-19 recovered patients. Study is conducted at single site, which is Srinivasa Heart Centre, Warangal, Telangana state in India for the duration of 4 months. The sample size is calculated 500 patients and the study is cohort, observational study. Patient consent has been taken before enrolment.
Detailed description
The aim of the study is to evaluate the prevalence and bring awareness of cardiovascular complications in COVID-19 recovered patients. Objectives of the study: 1. To study causes and risk factors of cardiac disorders associated with COVID-19 2. To identify different types of cardiac symptoms patients, present with 3. To study the impact of co-morbidities on COVID-19 recovered patients 4. To study treatment patterns and duration of therapy Plan to study: * To select the patient based on inclusion and exclusion criteria * To collect the patient information from case sheets and by patient interaction * To identify different types of cardiac disorders related to COVID-19 or its treatment regimen * To study the management of COVID-19 complication and related cardiovascular disorders Study Sites: Srinivasa Heart Centre, Warangal (T.S) Study Design: Observational cohort study Study Duration: 4 months Subject Eligibility: 1. Inclusion Criteria * Patients who are willing to participate * Patients having previous COVID-19 treatment record * Prescriptions reported during the study period * The prescription which is legible and complete 2. Exclusion Criteria * Patients who are not willing to participate * The patient having no history of COVID-19 and available data Source of the data: 1. Review of patient case sheet, prescription and lab reports 2. Personal interaction with patients and caregivers Sample size: 500 Patients
Interventions
BEHAVIORALDifference in gender, response to disease, diagnostic test values
Gender difference: Prevalence of disease in male vs female Response to disease: Which group is more prone to cardiac involvement Diagnostic tests: Diagnostic confirmation of disease
Sponsors
Kakatiya University
Study design
Observational model
COHORT
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to 100 Years
Healthy volunteers
No
Inclusion criteria
* Patients who are willing to participate * Patients having previous COVID-19 treatment record * Prescriptions reported during the study period * The prescription which is legible and complete
Exclusion criteria
* Patients who are not willing to participate * The patient having no history of COVID-19 and available data
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| ECG, Lipid profile, TMT, and 2D Echo | September 2021 to February 2022 | The following tests are performed to every individuals and relevant report are considered |
Countries
India
Outcome results
None listed